To overcome this limitation, amplification-free targeted sequencing has been first described in a Fuchs’ endothelial corneal dystrophy-associated Transcription Factor 4 (TCF4) CTG triplet repeat [49]. This evidence concerns the gene TCF4 and corneal endothelial dystrophy.